EVRYSDI (Roche Products Pty Ltd)
Product name
EVRYSDI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
180 (255 working days)
Active ingredients
risdiplam
Registration type
EOI
Indication
Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA).